Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Antoniades

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging studyOliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
Schizophrenia Research. Cognition|April 8, 2022
Evidence of discontinuity between psychosis-risk and non-clinical samples in the neuroanatomical correlates of social functionShalaila S Haas, Gaelle E Doucet, Mathilde Antoniades, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
Schizophrenia Research. Cognition|March 4, 2022
Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosisEmily P Hedges, Hannah Dickson, Stefania Tognin, et al.
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 17, 2019
Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging studyOliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
Schizophrenia Research. Cognition|April 8, 2022
Evidence of discontinuity between psychosis-risk and non-clinical samples in the neuroanatomical correlates of social functionShalaila S Haas, Gaelle E Doucet, Mathilde Antoniades, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Human Brain Mapping|October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosisGeorge Gifford, Nicolas Crossley, Sarah Morgan, et al.
Schizophrenia Research. Cognition|March 4, 2022
Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosisEmily P Hedges, Hannah Dickson, Stefania Tognin, et al.
Schizophrenia Bulletin Open|July 29, 2022
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for PsychosisStefania Tognin, Anja Richter, Matthew J Kempton, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
Pageof 3